Passive smoking, platelet function and atherosclerosis

Wiener Klinische Wochenschrift

Volumn 108, Issue 18, 1996, Pages 582-588

  Kritz, H ^a   Sinzinger, H ^a,b  

^a Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

atherosclerosis; hemostasis; passive smoking; platelets; thromboxane

Indexed keywords

ATHEROSCLEROSIS; HUMAN; PASSIVE SMOKING; REVIEW; THROMBOCYTE FUNCTION;

ARTERIOSCLEROSIS; BLOOD PLATELETS; CORONARY ARTERIOSCLEROSIS; HUMANS; PLATELET ACTIVATION; RISK FACTORS; SMOKING; THROMBOXANE A2; TOBACCO SMOKE POLLUTION;

EID: 0029826333     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Public Health Service (1983) The health consequences of smoking: cardiovascular disease: a report of the surgeon general. DHHS (PHS), 84-50204
2. Sternby NH (1980) Atherosclerosis, smoking and other risk factors. In: Gotto Jr AM, Smith LC, Allen B (eds) Atherosclerosis, Springer, New York, pp 67-70
3. Lakier JB (1992) Smoking and cardiovascular disease. Am J Med 93 [Suppl] I: 8-12
4. Steenland K (1992) Passive smoking and the risk of heart disease. JAMA 267: 94-99
5. Krupski WC (1991) The peripheral vascular consequences of smoking. Ann Vasc Surg 5: 291-304
6. Siegel M (1993) Involuntary smoking in the restaurant workplace - a review of employee exposure and health effects. JAMA 270: 490-493
7. Sinzinger H, Kefalides A (1982) Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet ii: 392-393
8. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz StA, Parmley WW (1993) Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 21: 225-232
9. Rodrigues M, Sinzinger H (1994) Platelet labeling - methodology and clinical applications. Thromb Res 76: 399-432
10. Pumphrey CW, Dawes J (1982) Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction. Am J Cardiol 50: 1258-1261
11. Marasini B, Biondi ML, Barbesti S, Zatta G, Agostoni A (1986) Cigarette smoking and platelet function. Thromb Res 44: 85-94
12. Dotevall A, Kutti J, Teger-Nilsson AC, Wadenvik H, Wilhelmsen L (1987) Platelet reactivity, fibrinogen and smoking. Eur J Haematol 38: 55-59
13. Wennmalm A (1982) Interaction of nicotine and prostaglandins in the cardiovascular system. Prostaglandins 23: 139-144
14. Khaifen ES, Klochkov VA (1987) Effect of passive smoking on physical tolerance of ischemic heart disease patients. Ter Arkh 59: 112-115
15. Aronow W (1978) Effect of passive smoking on angina pectoris. N Engl J Med 299: 21-24
16. Leone A, Bertanelli F, Mori L, Fabiato P, Bertanelli G (1992) Ventricular arrhythmias by passive smoke in patients with pre-existing myocardial infarction. J Am Coll Cardiol 19: 256A (abstract)
17. Pittilo RM, Mackie IM, Rowles OM, Machine SJ, Woolf N (1982) Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb Haemost 48: 173-176
18. Davis JW, Shelton L, Watanabe TS, Arnold J (1989) Passive smoking affects endothelium and platelets. Arch Intern Med 149: 386-389
19. Burghuber OC, Punzengruber C, Sinzinger H, Haber P, Silberbauer K (1985) Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest 90: 34-38
20. Sinzinger H, Virgolini I (1989) Are passive smokers at greater risk of thrombosis? Wien Klin Wochenschr 101: 694-698
21. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924
22. Martin JF. Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet ii: 1409-1411
23. Davis JW, Hartmann CR, Lewis Jr HD, Shelton L, Eigenberg D, Hassanein K, Hignite C, Ruttinger H (1985) Cigarette smoking-induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 105: 479-483
24. Davis JW, Shelton L, Eigenberg DA, Hignite C, Watanabe I (1985) Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37: 529-533
25. Davis JW. Shelton L, Hartman CR, Eigenberg D, Ruttinger H (1986) Smoking induced changes in endothelium and platelets are not affected by hydroxyethylrutosides. Br J Exp Pathol 67: 765-771
26. Davis JW. Shelton L, Eigenberg DA (1987) Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis 17: 66-69
27. Sun Y-P, Zhu B-Q, Sievers RE, Glantz SA, Parmley WW (1994) Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation 89: 2260-2265
28. Zhu B-Q, Sun Y-P, Sievers RE, Glantz SA, Parmley WW, Wolfe CL (1994) Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 89: 1282-1290
29. Moore S (1990) The role of platelets in the early stages of atherosclerosis. In: Kessler Ch (ed) Platelets and atherosclerosis. Springer, Berlin Heidelberg New York Tokyo, pp 1-9
30. Rivers RPA, Hathaway WE, Weston WL (1975) The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30: 311-316
31. Osteryud B, Lindahl U, Seljelid R (1980) Macrophages produce coagulant factors. FEBS Lett 120: 41-43
32. Chandler AB, Hand RA (1961) Phagocytosed platelets: a source of lipids in human thrombi and atherosclerotic plaques. Science 134: 946-949
33. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA (1980) Malondialdehyde alteration of low-density lipoprotein leads to cholesteryl ester accumulation in human monocyte-macrophaae. Proc Natl Acad Sci USA 77: 269-271
34. Hodenberg von E, Heinen S, Hauptmann M, Kreuzer J, Henningsen H, Kübler W (1990) Role of macrophages in atherogenesis-platelet/monocyte interactions. In: Kessler Ch (ed) Platelets and atherosclerosis. Springer. Berlin Heidelberg New York Tokyo, pp 19-24
35. Scheffler E, Wiest E, Woehrle J, Otto I, Schulz I, Huber L, Ziegler R, Dresel HA (1992) Smoking influences the atherogenic potential of low-density lipoprotein. Clin Invest 70: 263-268
36. 2 formation without affecting platelet survival in young healthy females. Thromb Haemost 68: 583-588
37. Miyaura S, Eguchi H, Johnson JM (1992) Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 70: 341-347
38. Benowitz NL, Fitzgerald GA, Wilson M, Thang Q (1993) Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 22: 1159-1167
39. Committee on Passive Smoking of the National Research Council (1986) The physiochemical nature of sidestream smoke and environmental tobacco smoke. Measuring exposure and assessing health effects. Washington DC, National Academy Press
40. Garland C, Barrett-Connor E, Suarez L, Criqui MH, Wingard DL (1985) Effect of passive smoking on ischemic heart disease mortality of non-smokers. A prospective study. Am J Epidemiol 121: 645-650
41. Hirayama T (1985) Passive smoking - a new target of epidemiology. Tokai J Exp Clin Med 10: 287-293
42. Lee PN, Chamberlain J, Alderson M (1986) Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer 54: 97-105
43. Svendsen KH, Kuller LH, Martin MJ, Ockene JK (1987) Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 126: 783-795
44. Helsing KJ, Sandler DP, Comstock GW, Chee E (1988) Heart disease mortality in non-smokers living with smokers. Am J Epidemiol 127: 915-922
45. He Y (1989) Women's passive smoking and coronary heart disease. Chung Hua Yu Fang I Hsueh Tsa Chin 23: 19-22
46. Humble C, Croft J, Gerber A, Casper M, Hames CG, Tyroler HA (1990) Passive smoking and 20-year cardiovascular disease mortality among non-smoking wives. Evans County, Georgia. Am J Public Health 80: 599-601
47. Hole DJ, Gillis CR, Chopra C, Hawthorne VM (1989) Passive smoking and cardiorespiratory health in a general population in the west of Scotland. Br Med J 299: 423-427
48. Dobson AJ, Alexander HM, Heller RF, Lloyd DM (1991) Passive smoking and the risk of heart attack or coronary death. Med J Aust 154: 793-797
49. Schouten EG, Dekker JM, Kok FJ, Le Cessie S, Van Houwelingen HC, Pool J, Vanderbroucke JP (1993) Risk ratio and rate ratio estimation in case-cohort designs: hypertension and cardiovascular mortality. Stat Med 12: 1733-1745
50. Wells A (1990) An estimate of adult mortality in the United States from passive smoking: a response to criticism. Environ Int 16: 187-193